Evidence map›Paper›PMID 28673972›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.

Xiaolei Pan, William C Drosopoulos, Louisa Sethi, Advaitha Madireddy, Carl L Schildkraut, Dong Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 145 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. CHAMP1 complex promotes heterochromatin assembly and reduces replication stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Mechanisms and genomic implications of break-induced replication.Nature structural & molecular biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaolei PanDepartment of Biomedical Science, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY 11568.
William C DrosopoulosDepartment of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461.
Louisa SethiDepartment of Biomedical Science, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY 11568.
Advaitha MadireddyDepartment of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461.
Carl L SchildkrautDepartment of Cell Biology, Albert Einstein College of Medicine, New York, NY 10461.
Dong ZhangDepartment of Biomedical Science, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY 11568; dzhang12@NYIT.edu.
Albert Einstein College of Medicine · USNew York Institute of Technology · US

Funding

DNA REPLICATION INITIATION SITES IN MAMMALIAN CELLSR01GM045751 · NIGMS · YESHIVA UNIVERSITY · PI SCHILDKRAUT, CARL L · 1992 to 2023
$13.4M
The multifaceted role of the Fanconi anemia tumor suppressor pathway in facilitating DNA replicationK99HL136870 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MADIREDDY, ADVAITHA · 2017 to 2018
$345k
NHLBI NIH HHS K99 HL136870NIGMS NIH HHS R01 GM045751
6 · The paper itself

Abstract

In the mammalian genome, certain genomic loci/regions pose greater challenges to the DNA replication machinery (i.e., the replisome) than others. Such known genomic loci/regions include centromeres, common fragile sites, subtelomeres, and telomeres. However, the detailed mechanism of how mammalian cells cope with the replication stress at these loci/regions is largely unknown. Here we show that depletion of FANCM, or of one of its obligatory binding partners, FAAP24, MHF1, and MHF2, induces replication stress primarily at the telomeres of cells that use the alternative lengthening of telomeres (ALT) pathway as their telomere maintenance mechanism. Using the telomere-specific single-molecule analysis of replicated DNA technique, we found that depletion of FANCM dramatically reduces the replication efficiency at ALT telomeres. We further show that FANCM, BRCA1, and BLM are actively recruited to the ALT telomeres that are experiencing replication stress and that the recruitment of BRCA1 and BLM to these damaged telomeres is interdependent and is regulated by both ATR and Chk1. Mechanistically, we demonstrated that, in FANCM-depleted ALT cells, BRCA1 and BLM help to resolve the telomeric replication stress by stimulating DNA end resection and homologous recombination (HR). Consistent with their roles in resolving the replication stress induced by FANCM deficiency, simultaneous depletion of BLM and FANCM, or of BRCA1 and FANCM, leads to increased micronuclei formation and synthetic lethality in ALT cells. We propose that these synthetic lethal interactions can be explored for targeting the ALT cancers.

Indexed as

Ataxia Telangiectasia Mutated ProteinsBRCA1 ProteinCell LineCheckpoint Kinase 1DNA HelicasesDNA ReplicationHomologous RecombinationHumansRecQ HelicasesTelomereTelomere HomeostasisAtaxia Telangiectasia Mutated ProteinsATR protein, humanBloom syndrome proteinBRCA1 ProteinBRCA1 protein, humanCheckpoint Kinase 1CHEK1 protein, humanDNA HelicasesFANCM protein, humanRecQ HelicasesALT telomeresBLMBRCA1FANCMreplication stress

Identifiers

PMID28673972
PMCPMC5530707
OpenAlexW2733026364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.